Starck J, Sarkar R, Romana M, Bhargava A, Scarpa A L, Tanaka M, Chamberlain J W, Weissman S M, Forget B G
Department of Internal Medicine, Yale University School of Medicine, New Haven, CT 06520-8021.
Blood. 1994 Sep 1;84(5):1656-65.
Two lines of transgenic mice carrying a normal 40-kb Kpn I beta-globin cluster transgene lacking the locus control region (LCR) were analyzed for the expression of human gamma- and beta-globin genes during mouse development. After RNase protection assays, the ratios of human G gamma-, A gamma-, or beta-mRNAs relative to endogenous mouse zeta + alpha mRNAs were obtained for each stage of development. The two gamma transgenes were expressed in day-11.5 blood (embryonic stage) and day-13.5 blood (early fetal stage), but their expression was markedly decreased by day 16.5 of fetal life. Expression of the beta transgene was essentially absent at day 13.5, appeared at a low level by day 16.5, and was maximal by day 18.5, reaching a level similar to that observed in adult mice. Therefore, developmentally regulated expression of the human gamma- and beta-globin transgenes was obtained in the absence of the LCR. The relative expression of human gamma- and beta-globin genes was also examined in mice carrying 40-kb Kpn I beta-cluster transgenes with two different base substitutions associated with nondeletion forms of hereditary persistence of fetal hemoglobin (HPFH), -202 C-->G G gamma HPFH and -117 G-->A A gamma HPFH. The ratio of G gamma- to beta-globin transcripts was markedly increased in red blood cells of adult mice from three different lines carrying the transgene with the -202 G gamma HPFH mutation. This result confirms our previous preliminary results (Tanaka et al: Ann NY Acad Sci, 612:167, 1990) indicating that the -202 G gamma HPFH phenotype was reproduced in transgenic mice. The relatively low levels of G gamma-mRNA expression in adult mice carrying the non-HPFH transgene excludes a major influence of the 3' beta-globin enhancer, present upstream of the G gamma gene because of the tandem repeat insertion, as a factor in the persistent G gamma gene expression observed in blood of adult mice carrying the -202 G gamma HPFH transgene. This conclusion is also supported by the fact that, in mice carrying the -117 A gamma HPFH transgene, G gamma-globin mRNA was detected in blood of adult animals only at low levels similar to that observed in the non-HPFH lines. However, the A gamma-HPFH phenotype was not reproduced in the transgenic lines carrying the -117A gamma HPFH mice.
对两条携带正常40kb Kpn I β-珠蛋白基因簇转基因但缺乏基因座控制区(LCR)的转基因小鼠品系,分析了小鼠发育过程中人类γ-和β-珠蛋白基因的表达情况。经核糖核酸酶保护分析,获得了发育各阶段人类Gγ-、Aγ-或β-信使核糖核酸(mRNA)相对于内源性小鼠ζ+α mRNA的比率。两个γ转基因在胚胎期11.5天的血液和胎儿早期13.5天的血液中表达,但在胎儿期16.5天时其表达显著下降。β转基因在13.5天时基本不表达,在16.5天时低水平出现,在18.5天时达到最大值,达到与成年小鼠中观察到的水平相似。因此,在没有LCR的情况下获得了人类γ-和β-珠蛋白转基因的发育调控表达。还在携带40kb Kpn I β-基因簇转基因且有两种与非缺失型胎儿血红蛋白遗传性持续存在(HPFH)相关的不同碱基替换的小鼠中,检测了人类γ-和β-珠蛋白基因的相对表达,即-202 C→G Gγ HPFH和-117 G→A Aγ HPFH。在携带-202 Gγ HPFH突变转基因的三个不同品系的成年小鼠红细胞中,Gγ-与β-珠蛋白转录本的比率显著增加。这一结果证实了我们之前的初步结果(田中等人:《纽约科学院学报》,612:167,1990年),表明在转基因小鼠中再现了-202 Gγ HPFH表型。携带非HPFH转基因的成年小鼠中Gγ-mRNA表达水平相对较低,排除了由于串联重复插入而存在于Gγ基因上游的3'β-珠蛋白增强子作为携带-202 Gγ HPFH转基因成年小鼠血液中持续Gγ基因表达的一个因素的主要影响。这一结论也得到以下事实的支持,即在携带-117 Aγ HPFH转基因的小鼠中,仅在成年动物血液中检测到低水平的Gγ-珠蛋白mRNA,与在非HPFH品系中观察到的水平相似。然而,在携带-117Aγ HPFH小鼠的转基因品系中未再现Aγ-HPFH表型。